Pulmatrix PULM
NASDAQ PULM
$1.50 0.00 (-0.33%)
As of: Aug 21, 2026 · 3:45 PM EDT

Pulmatrix (PULM) Free Cash Flow (2013 - 2026)

Pulmatrix (PULM) posted Free Cash Flow of -$1.1 million for Q1 2026, down 51.13% sequentially from -$706000.0 in Q4 2025, and up 40.72% YoY from -$758231.3 in Q1 2025.

Pulmatrix (PULM) Free Cash Flow (2013 - 2026) Analysis & Trends

Pulmatrix has reported Free Cash Flow for 14 years, with the latest figure at -$1.1 million in Q1 2026.

  • Quarterly Free Cash Flow rose 40.72% year-over-year to -$1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.7 million (up 54.21% YoY) and the FY2025 annual result came in at -$5.4 million, up 51.23% from the prior year.
  • Free Cash Flow fell to -$1.1 million in Q1 2026 per PULM's latest filing, from -$706000.0 in the prior quarter.
  • Over five years, Free Cash Flow peaked at -$706000.0 in Q4 2025 and troughed at -$6.2 million in Q1 2022.
  • A 5-year average of -$3.1 million and a median of -$2.7 million in 2024 frame the typical range for Free Cash Flow.
  • The sharpest annual moves came in 2023 and 2024: Free Cash Flow surged 77.35% in 2023, then slumped 57.05% in 2024.
  • Over 5 years, Free Cash Flow stood at -$5.0 million in 2022, then soared by 77.35% to -$1.1 million in 2023, then plunged by 57.05% to -$1.8 million in 2024, then surged by 60.36% to -$706000.0 in 2025, then sank by 51.13% to -$1.1 million in 2026.
  • According to Business Quant data, Free Cash Flow over the past three periods registered -$1.1 million, -$706000.0, and -$1.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Free Cash Flow (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.01 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 572.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn -
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -563.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 437.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 292.04 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 433.84 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -95.09 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 477.44 Mn
10 Pulmatrix 5.46 Mn 5.46 Mn - -1.11 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.11 Mn
Jun 30, 2026 -1.11 Mn
Mar 31, 2026 -1.07 Mn
Mar 31, 2026 -1.07 Mn
Dec 31, 2025 -706,000.00
Dec 31, 2025 -706,000.00
Sep 30, 2025 -1.03 Mn
Sep 30, 2025 -1.03 Mn
Jun 30, 2025 -1.88 Mn
Jun 30, 2025 -1.88 Mn
Mar 31, 2025 -1.80 Mn
Mar 31, 2025 -1.80 Mn
Dec 31, 2024 -1.78 Mn
Dec 31, 2024 -1.78 Mn
Sep 30, 2024 -2.54 Mn
Sep 30, 2024 -2.54 Mn
Jun 30, 2024 -4.12 Mn
Jun 30, 2024 -4.12 Mn
Mar 31, 2024 -2.68 Mn
Mar 31, 2024 -2.68 Mn